Avista Healthcare Partners, a NYC-based private equity firm, announced the final closing of Avista Healthcare Partners VI, at $1.5 Billion.
The Fund, which exceeded its $1.25 Billion target, represents one of the largest pools of private capital focused on investments across high-growth middle-market product and technology healthcare companies in North America and Europe.
Fund VI is a continuation of Avista’s strategy, leveraging the firm’s deep domain knowledge and expertise, driving value creation and growth in product and technology healthcare businesses.
Founded in 2005 and led by David Burgstahler, Chief Executive Officer, Avista Capital is a private equity firm with over $8 Billion invested in more than 45 growth-oriented healthcare businesses globally. It partners with businesses that feature management teams, stable cash flows and growth prospects – targeting healthcare product and technology businesses with clear scale potential across six sub-sectors experiencing strong tailwinds. The team is supported by a group of strategic executives enhancing the entire investment process through strategic insight, operational oversight and senior counsel, which helps drive growth and performance, while fostering sustainable businesses and creating long-term value for all stakeholders.
FinSMEs
04/03/2024